Clinical Trial Update: Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating SGLT2 inhibitors in patients with diabetes and heart failure, including potential effects on ventricular arrhythmia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure
• Ventricular Arrhythmia

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Diabetes Mellitus, Heart Failure | Phase 4 | Status: COMPLETED